CRBP
Corbus Pharmaceuticals Holding
7.50$
-3.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -22.1% | +344.8% | +20.9% | +8.0% | -5.1% | -10.2% | -10.6% | -12.4% | +53.6% | -14.1% | -12.1% | |
| – | -24.5% | +416.8% | +21.9% | +8.5% | -4.9% | -10.2% | -10.6% | -12.4% | +55.2% | -14.0% | -14.5% | |
| – | +22.0% | +2.8% | +70.0% | -19.0% | -11.5% | +9.9% | +6.1% | +34.6% | +5.6% | -8.6% | -10.3% | |
| – | -27.2% | +474.5% | +22.7% | +8.2% | -6.5% | -10.9% | -12.2% | -10.8% | +57.7% | -15.5% | -14.9% | |
| – | – | – | – | – | – | – | – | +0.0% | +0.0% | – | – | |
| – | -2.2% | -18.2% | -8.1% | -48.3% | -1.6% | -4.7% | +9.9% | +23.2% | +19.1% | -12.3% | +36.4% | |
| – | +1.1% | -18.7% | -7.5% | -51.5% | +1.7% | -1.7% | +14.7% | +28.0% | +21.3% | -12.3% | +18.4% | |
| – | -8.3% | -18.2% | -14.5% | -87.3% | +2.8% | +2.7% | +2.7% | +2.8% | -6.3% | -26.2% | -17.1% | |
| – | -32.6% | -34.5% | -44.7% | +150.6% | +65.8% | -15.0% | -2.0% | -31.3% | -19.2% | -80.4% | +1,107.8% | |
| – | -2,320.1% | – | +29.5% | +19.9% | -5.4% | -10.8% | -12.7% | -17.0% | +60.1% | -14.3% | -19.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -36.4% | +0.0% | +327.2% | +1.4% | +0.2% | +0.3% | +0.5% | +8.2% | +40.5% | +3.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.